Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Yunfu Cui"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Among primary liver cancers, hepatocellular carcinoma is the most common pathological type. Its onset is insidious, and most patients have no obvious discomfort in the early stage, so it is found late, and the opportunity for surgical radical treatme
Externí odkaz:
https://doaj.org/article/4f60d7b321ea45fbb044a9158d5a4329
Autor:
Jianjun Gao, Wujiang Shi, Jiangang Wang, Canghai Guan, Qingfu Dong, Jialin Sheng, Xinlei Zou, Zhaoqiang Xu, Yifei Ge, Chengru Yang, Jiehan Li, Haolin Bao, Xiangyu Zhong, Yunfu Cui
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Epigenetic changes are heritable changes in gene expression without changes in the nucleotide sequence of genes. Epigenetic changes play an important role in the development of cancer and in the process of malignancy metastasis. Previous studies have
Externí odkaz:
https://doaj.org/article/e124e97beb4348d0a662fd5ff9e41fae
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundNon-alcoholic fatty liver disease (NAFLD), which includes simple steatosis (SS) and non-alcoholic steatohepatitis (NASH), is a significant contributor to liver disease on a global scale. The change of immunity-related genes (IRGs) expressio
Externí odkaz:
https://doaj.org/article/472657e5c8ca41d1bc88e5d43633cacf
Autor:
Yi Xu, Yue Yao, Liang Yu, Xiaoxin Zhang, Xiaowen Mao, Sze Keong Tey, Samuel Wan Ki Wong, Cherlie Lot Sum Yeung, Tung Him Ng, Melody YM Wong, Chi‐Ming Che, Terence Kin Wah Lee, Yi Gao, Yunfu Cui, Judy Wai Ping Yam
Publikováno v:
Journal of Extracellular Vesicles, Vol 12, Iss 8, Pp n/a-n/a (2023)
Abstract Small extracellular vesicles (sEVs) play a key role in exchanging cargoes between cells in tumour microenvironment. This study aimed to elucidate the functions and mechanisms of hepatocellular carcinoma (HCC) derived sEV‐clathrin light cha
Externí odkaz:
https://doaj.org/article/ac68c9a881f042b6a3823d140832ccae
Autor:
Junqi You, Haoming Xia, Ziyue Huang, Risheng He, Xudong Zhao, Jiali Chen, Sidi Liu, Yi Xu, Yunfu Cui
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Hepatocellular carcinoma (HCC) is a highly malignant tumor that carries a significant risk of morbidity and mortality. This type of cancer is prevalent in Asia due to the widespread presence of risk factors. Unfortunately, HCC often goes undetected u
Externí odkaz:
https://doaj.org/article/429e6c568cf6480299f156034a4308bf
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Pancreatic cancer (PC) is extremely malignant and shows limited response to available immunotherapies due to the hypoxic and immunosuppressive nature of its tumor microenvironment (TME). The aggregation of immune cells (B cells, T cells, dendritic ce
Externí odkaz:
https://doaj.org/article/0c9ae202f4b146ffbdbdb2720f8a9560
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Afatinib is an irreversible epidermal growth factor receptor tyrosine kinase inhibitor, and it plays a role in hepatocellular carcinoma (LIHC). This study aimed to screen a key gene associated with afatinib and identify its potential cand
Externí odkaz:
https://doaj.org/article/b90f8f65fb334951b2e85f8ecab99495
Autor:
Qingfu Dong, Haolin Bao, Jiangang Wang, Wujiang Shi, Xinlei Zou, Jialin Sheng, Jianjun Gao, Canghai Guan, Haoming Xia, Jinglin Li, Pengcheng Kang, Yi Xu, Yunfu Cui, Xiangyu Zhong
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
In recent years, the prevalence of metabolic-associated fatty liver disease (MAFLD) has reached pandemic proportions as a leading cause of liver fibrosis worldwide. However, the stage of liver fibrosis is associated with an increased risk of severe l
Externí odkaz:
https://doaj.org/article/c1c61544b484405d932c7934fafa3512
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Immunotherapy has been a key option for the treatment of many types of cancer. A positive response to immunotherapy is heavily dependent on tumor microenvironment (TME) interaction. However, in pancreatic adenocarcinoma (PAAD), the associ
Externí odkaz:
https://doaj.org/article/2deb021fc3ef4b0593b66ab373e2e8ca
Autor:
Juxian Sun, Rongping Guo, Xinyu Bi, Mengchao Wu, Zhaoyou Tang, Wan Yee Lau, Shusen Zheng, Xuehao Wang, Jinming Yu, Xiaoping Chen, Jia Fan, Jiahong Dong, Yongjun Chen, Yunfu Cui, Chaoliu Dai, Chihua Fang, Shuang Feng, Zhili Ji, Weidong Jia, Ningyang Jia, Gong Li, Jing Li, Qiu Li, Jiangtao Li, Tingbo Liang, Lianxin Liu, Shichun Lu, Yi Lv, Yilei Mao, Yan Meng, Zhiqiang Meng, Feng Shen, Jie Shi, Huichuan Sun, Kaishan Tao, Gaojun Teng, Xuying Wan, Tianfu Wen, Liqun Wu, Jinglin Xia, Mingang Ying, Jian Zhai, Leida Zhang, Xuewen Zhang, Zhiwei Zhang, Haiping Zhao, Donghai Zheng, Xuting Zhi, Jie Zhou, Cuncai Zhou, Jian Zhou, Zhaochong Zeng, Kangshun Zhu, Minshan Chen, Jianqiang Cai, Shuqun Cheng
Publikováno v:
Liver Cancer, Pp 1-14 (2022)
Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past severa
Externí odkaz:
https://doaj.org/article/901ff635b0164703893ca20527e85fde